Trials / Completed
CompletedNCT01237821
Comparing OTC Acne Treatment to Prescription Regimen
A MULTI-CENTER, DOUBLE-BLIND CLINICAL TRIAL TO EVALUATE THE SAFETY AND EFFICACY OF TWO ACNE CREAMS IN SUBJECTS WITH MILD TO MODERATE ACNE VULGARIS
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 66 (actual)
- Sponsor
- Milton S. Hershey Medical Center · Academic / Other
- Sex
- All
- Age
- 18 Years – 50 Years
- Healthy volunteers
- Accepted
Summary
This research is being done to find out the safety and efficacy of two acne creams, Effaclar and Benzaclin when used twice daily with a topical retinoid. Effaclar and Benzaclin are FDA approved for the treatment of acne.
Detailed description
There are many products on the market to treat facial acne. The medication that this study will be evaluating, Benzaclin and Retin-A have been approved by the FDA and is available by prescription, Effaclar is an over the counter product. This study will hopefully recognize a treatment combination that is effective in reducing acne vulgaris in adults 18-50.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | BenzaClin | Topical, 1% Clindamycin/5% Benzoyl Peroxide, BID, 12 weeks |
| DRUG | Effaclar | Topical, Bid, 12 weeks |
Timeline
- Start date
- 2010-10-01
- Primary completion
- 2011-08-01
- Completion
- 2011-10-01
- First posted
- 2010-11-10
- Last updated
- 2019-07-16
- Results posted
- 2019-07-16
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01237821. Inclusion in this directory is not an endorsement.